Vivos Therapeutics Insider Buys Spark Mild Optimism Amid Sharp Stock Slide
Insider purchase of 250k Vivos Therapeutics shares at $0.41 hints at modest optimism, but the company’s steep decline and lack of earnings raise caution for investors.
3 minutes to read
